|Videos|August 3, 2020

Unmet Needs in Chronic Fibrosing ILD With Progressive Phenotype

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

CDC headquarters | Image Credit: Katherine Welles - stock.adobe.com

Unexplained Pauses Hit Nearly Half of Monthly-Updated CDC Databases, Raising Transparency Concerns

ByBrooke McCormick

January 26th 2026

RSV vaccine | Image Credit: Peter Hansen - stock.adobe.com

RSV Vaccination Effective in Older Adults, but Protection Declines Over Time

ByBrooke McCormick

November 24th 2025

A recent study reveals a heightened stroke risk in asthma patients recovering from severe COVID-19, emphasizing the need for proactive monitoring and management. | Image Credit: donfiore - stock.adobe.com

Severe COVID-19 Increases Stroke Risk for Patients With Asthma

ByAshley Gallagher

October 30th 2025

A concerning trend for clinicians to consider when supporting exacerbation recovery is patients’ perception that the goal itself—as they have defined it—is actually an impossibility. | Image Credit: LIGHTFIELD STUDIOS - stock.adobe.com

Clinical and Patient Definitions of Acute COPD Exacerbation Recovery Differ

ByKevin Kunzmann

October 30th 2025

The real-world data support the long-term value of mepolizumab as an add-on maintenance therapy in severe asthma. | gustavofrazao - stock.adobe.com

Mepolizumab Reduces Health Care Resource Utilization, Work Impairment in Severe Asthma

ByRose McNulty

October 26th 2025

Latest CME

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

On-Demand Virtual Symposium

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

On-Demand Virtual Symposium

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

1.5 Credits / Neurology, Psychiatry

Unmet Needs in Chronic Fibrosing ILD With Progressive Phenotype

Newsletter

Related Content

Unexplained Pauses Hit Nearly Half of Monthly-Updated CDC Databases, Raising Transparency Concerns

RSV Vaccination Effective in Older Adults, but Protection Declines Over Time

Severe COVID-19 Increases Stroke Risk for Patients With Asthma

Clinical and Patient Definitions of Acute COPD Exacerbation Recovery Differ

Mepolizumab Reduces Health Care Resource Utilization, Work Impairment in Severe Asthma

Latest CME

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial

MID Models Reduce Adverse Events, Lower Costs in Oncology: Kenneth Komorny, PharmD, BCPS

FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads

Contributor: Reimagining Beneficiary Engagement in Accountable Care Models to Make America Healthy Again